CA2232242A1 - Long wavelength engineered fluorescent proteins - Google Patents

Long wavelength engineered fluorescent proteins

Info

Publication number
CA2232242A1
CA2232242A1 CA002232242A CA2232242A CA2232242A1 CA 2232242 A1 CA2232242 A1 CA 2232242A1 CA 002232242 A CA002232242 A CA 002232242A CA 2232242 A CA2232242 A CA 2232242A CA 2232242 A1 CA2232242 A1 CA 2232242A1
Authority
CA
Canada
Prior art keywords
fluorescent proteins
long wavelength
engineered fluorescent
wavelength engineered
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002232242A
Other languages
French (fr)
Other versions
CA2232242C (en
Inventor
Roger Y. Tsien
Andrew B. Cubitt
Roger Heim
Mats F. Ormo
S. James Remington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon State Board of Higher Education
Vertex Pharmaceuticals San Diego LLC
University of California
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2232242A1 publication Critical patent/CA2232242A1/en
Application granted granted Critical
Publication of CA2232242C publication Critical patent/CA2232242C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving

Abstract

Engineered fluorescent proteins, nucleic acids encoding them and methods of use.
CA002232242A 1996-08-16 1997-08-15 Long wavelength engineered fluorescent proteins Expired - Lifetime CA2232242C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2405096P 1996-08-16 1996-08-16
US60/024,050 1996-08-16
US08/706,408 US6124128A (en) 1996-08-16 1996-08-30 Long wavelength engineered fluorescent proteins
US08/706,408 1996-08-30
PCT/US1997/014593 WO1998006737A1 (en) 1996-08-16 1997-08-15 Long wavelength engineered fluorescent proteins

Publications (2)

Publication Number Publication Date
CA2232242A1 true CA2232242A1 (en) 1998-02-19
CA2232242C CA2232242C (en) 2008-10-21

Family

ID=26697970

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002232242A Expired - Lifetime CA2232242C (en) 1996-08-16 1997-08-15 Long wavelength engineered fluorescent proteins

Country Status (10)

Country Link
US (6) US6124128A (en)
EP (2) EP0886644B1 (en)
JP (1) JP4232992B2 (en)
AT (1) ATE280178T1 (en)
AU (1) AU727088B2 (en)
CA (1) CA2232242C (en)
DE (1) DE69731285T2 (en)
DK (1) DK0886644T3 (en)
ES (1) ES2231890T3 (en)
WO (1) WO1998006737A1 (en)

Families Citing this family (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69604298T2 (en) * 1995-09-22 2000-05-18 Bioimage A S Soeborg VARIANTS OF THE GREEN FLUORESCENCE PROTEIN, GFP
US6803188B1 (en) * 1996-01-31 2004-10-12 The Regents Of The University Of California Tandem fluorescent protein constructs
US6124128A (en) 1996-08-16 2000-09-26 The Regents Of The University Of California Long wavelength engineered fluorescent proteins
US6593135B2 (en) * 1996-08-16 2003-07-15 The State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Long wavelength engineered fluorescent proteins
WO1998021355A1 (en) 1996-11-15 1998-05-22 Life Technologies, Inc. Mutants of green fluorescent protein
CA2281648A1 (en) 1997-02-13 1998-08-20 Memorial Sloan-Kettering Cancer Center Hybrid molecules for optically detecting changes in cellular microenvironments
DE69840146D1 (en) * 1997-03-14 2008-12-04 Univ California FLUORESCENCE PROTEIN SENSORS FOR THE DETECTION OF ANALYTES
US6197928B1 (en) 1997-03-14 2001-03-06 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
US7105307B2 (en) 1997-08-30 2006-09-12 Cyclacel, Ltd. Compositions and methods for screening for modulators of enzymatic activity
US6881683B2 (en) * 1998-02-05 2005-04-19 Asm Japan K.K. Insulation film on semiconductor substrate and method for forming same
US7090976B2 (en) * 1999-11-10 2006-08-15 Rigel Pharmaceuticals, Inc. Methods and compositions comprising Renilla GFP
US6150176A (en) * 1998-06-09 2000-11-21 The Regents Of The University Of California Fluorescent protein sensors for measuring the pH of a biological sample
US6140132A (en) * 1998-06-09 2000-10-31 The Regents Of The University Of California Fluorescent protein sensors for measuring the pH of a biological sample
AU5429399A (en) * 1998-08-08 2000-02-28 Imperial Cancer Research Technology Limited Fluorescent assay for biological systems
US6972182B1 (en) * 1999-02-26 2005-12-06 Cyclacel, Ltd. Methods and compositions using coiled binding partners
US6828106B2 (en) * 1999-02-26 2004-12-07 Cyclacel Limited Methods and compositions using coiled binding partners
US6670144B1 (en) 1999-02-26 2003-12-30 Cyclacel, Ltd. Compositions and methods for monitoring the phosphorylation of natural binding partners
US6656696B2 (en) 1999-02-26 2003-12-02 Cyclacel Compositions and methods for monitoring the phosphorylation of natural binding partners
US6716614B1 (en) * 1999-09-02 2004-04-06 Lexicon Genetics Incorporated Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
US6541252B1 (en) 2000-05-19 2003-04-01 Lexicon Genetics Incorporated Human kinases and polynucleotides encoding the same
US6562563B1 (en) 1999-11-03 2003-05-13 Mitokor Compositions and mehtods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions
US7060506B2 (en) 2000-01-31 2006-06-13 Cyclacel, Ltd. Compositions and methods for monitoring the modification of modification dependent binding partner polypeptides
US6656700B2 (en) 2000-05-26 2003-12-02 Amersham Plc Isoforms of human pregnancy-associated protein-E
US6686188B2 (en) 2000-05-26 2004-02-03 Amersham Plc Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
US6808874B2 (en) 2000-06-13 2004-10-26 Cyclacel Ltd. Methods of monitoring enzyme activity
US20040072995A1 (en) * 2000-06-19 2004-04-15 Bjorn Sara P. Novel fluorescent proteins
WO2001098338A2 (en) * 2000-06-19 2001-12-27 Bioimage As Fluorescent proteins
US6667153B1 (en) 2000-06-26 2003-12-23 Susan Margaret Thomas Composition and method for detecting mutagens
US20020123474A1 (en) * 2000-10-04 2002-09-05 Shannon Mark E. Human GTP-Rho binding protein2
WO2002070705A2 (en) * 2000-10-27 2002-09-12 Lexicon Genetics Incorporated Human 7tm proteins and polynucleotides encoding them
JP2004531209A (en) * 2000-10-30 2004-10-14 レキシコン・ジェネティクス・インコーポレーテッド Novel human 7TM protein and polynucleotide encoding the same
AU2002230524A1 (en) 2000-11-16 2002-05-27 California Institute Of Technology Apparatus and methods for conducting assays and high throughput screening
US7005511B2 (en) 2001-02-26 2006-02-28 The Regents Of The University Of California Fluorescent protein variants and methods for making same
JP3929250B2 (en) * 2001-03-08 2007-06-13 株式会社ルネサステクノロジ Semiconductor device
US7015310B2 (en) * 2001-03-12 2006-03-21 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Oxidation reduction sensitive green fluorescent protein variants
GB0109858D0 (en) * 2001-04-23 2001-06-13 Amersham Pharm Biotech Uk Ltd Fluorscent proteins
US20030044847A1 (en) * 2001-05-15 2003-03-06 Sidney Pestka Methods for anlyzing interactions between proteins in live and intact cells
AU2002309989A1 (en) * 2001-05-18 2002-12-03 Rigel Pharmaceuticals, Incorporated Directed evolution of protein in mammalian cells
US7354735B2 (en) * 2001-05-24 2008-04-08 Hong Kong University Of Science And Technology Nucleic acid encoding fluorescent protein constructs and methods for detecting apoptosis
JP3829252B2 (en) * 2001-06-08 2006-10-04 独立行政法人理化学研究所 Fluorescent protein
US20040078837A1 (en) * 2001-08-02 2004-04-22 Shannon Mark E. Four human zinc-finger-containing proteins: MDZ3, MDZ4, MDZ7 and MDZ12
US20040096880A1 (en) * 2001-08-07 2004-05-20 Kmiec Eric B. Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
EP1423537A4 (en) * 2001-08-07 2006-11-29 Univ Delaware Compositions and methods for the prevention and treatment of huntington's disease
WO2003017937A2 (en) * 2001-08-22 2003-03-06 University Of Hawaii Physalia fluorescent proteins
US20030027315A1 (en) * 2001-09-24 2003-02-06 Ada Yonath Methods of growing crystals of free and antibiotic complexed large ribosomal subunits, and methods of rationally designing or identifying antibiotics using structure coordinate data derived from such crystals
EP1440319A2 (en) * 2001-10-01 2004-07-28 BioImage A/S An improved method to detect interactions between cellular components in intact living cells, and to extract quantitative information relating to those interactions by fluorescence redistribution
GB0123856D0 (en) * 2001-10-05 2001-11-28 Amersham Pharm Biotech Uk Ltd Method for determining cell cycle position
WO2003040312A2 (en) * 2001-10-24 2003-05-15 University Of Hawaii Multifunctional green fluorescent protein and uses thereof
US7985553B2 (en) * 2001-10-29 2011-07-26 Nathaniel Heintz Method for isolating cell type-specific mRNAs
US7846671B2 (en) 2002-01-28 2010-12-07 Bristol-Myers Squibb Company Methods of screening for agents that modulate the interaction of RGS and Gαq and urinary incontinence
GB0207533D0 (en) 2002-04-02 2002-05-08 Oxford Glycosciences Uk Ltd Protein
US20050181464A1 (en) * 2002-04-04 2005-08-18 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from bacteria
US7335488B2 (en) * 2002-04-05 2008-02-26 The Chinese University Of Hong Kong Fluorescent proteins
US7795493B2 (en) 2002-08-21 2010-09-14 Revivicor, Inc. Porcine animals lacking any expression of functional alpha 1, 3 galactosyltransferase
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US7056683B2 (en) * 2002-11-12 2006-06-06 Massachusetts Institute Of Technology Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities
WO2004090115A2 (en) 2003-04-04 2004-10-21 Stratagene Renilla gfp mutants with increased fluorescent intensity and special shift
US20050037364A1 (en) 2003-08-13 2005-02-17 International Business Machines Corporation Techniques for recording signals
US20050048493A1 (en) * 2003-08-27 2005-03-03 Zyomyx, Inc. Film layer for detection of immobilized analytes
US7279275B2 (en) 2003-11-03 2007-10-09 Washington University Methods and compositions for detection of segmented negative strand RNA viruses
JP2008507294A (en) 2004-07-26 2008-03-13 ダウ グローバル テクノロジーズ インコーポレイティド Method for improved protein expression by strain genetic manipulation
EP2482075A1 (en) 2004-12-01 2012-08-01 Proteologics, Ltd Ubiquitin ligase assays and related reagents
WO2008036060A2 (en) 2005-04-05 2008-03-27 Allergan, Inc. Clostridial toxin activity assays
SG184709A1 (en) 2005-05-18 2012-10-30 Ablynx Nv Improved nanobodies™ against tumor necrosis factor-alpha
CA2960105A1 (en) 2005-05-20 2006-11-23 Ablynx Nv Single domain vhh antibodies against von willebrand factor
US8362250B2 (en) 2005-05-24 2013-01-29 Enzo Biochem, Inc. Fluorescent dyes and compounds, methods and kits useful for identifying specific organelles and regions in cells of interest
NZ565711A (en) 2005-08-09 2011-10-28 Revivicor Inc Transgenic ungulates expressing a porcine CTLA4 peptide fused to an immunoglobulin
DK1954713T3 (en) * 2005-11-04 2013-02-11 Evrogen Jsc MODIFIED GREEN FLUORESCING PROTEINS AND METHODS FOR USING THE SAME
EP2347775B1 (en) 2005-12-13 2020-04-15 President and Fellows of Harvard College Scaffolds for cell transplantation
JP4719226B2 (en) * 2006-01-26 2011-07-06 Ｎｅｃソフト株式会社 How to change the fluorescence wavelength of fluorescent protein
BRPI0708970A2 (en) * 2006-03-21 2011-06-21 Wyeth Corp method for treating a subject with a disease or disorder characterized by amyloid deposition of a-beta; method of inhibiting or reducing the accumulation of amyloid deposits of a-beta in a subject; method of inhibiting or reducing neurodegeneration in a subject; and method of inhibiting or reducing cognitive decline, or improving cognition, in a subject
GB0606430D0 (en) * 2006-03-31 2006-05-10 Ge Healthcare Uk Ltd Method for cell based assays
US20080004410A1 (en) * 2006-06-30 2008-01-03 Yu-Chin Lai Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
GB0624462D0 (en) * 2006-12-07 2007-01-17 Ge Healthcare Ltd Method for determining gentoxicity
WO2008074839A2 (en) 2006-12-19 2008-06-26 Ablynx N.V. Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
WO2008074840A2 (en) 2006-12-19 2008-06-26 Ablynx N.V. Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
JP5370890B2 (en) * 2007-03-16 2013-12-18 公益財団法人東京都医学総合研究所 Cell cycle visualization probe
BRPI0810120A2 (en) 2007-04-27 2014-11-11 Dow Global Technologies Inc PROCESS TO QUICKLY SELECT MICROBIAN HOST FOR THE IDENTIFICATION OF CERTAIN BETTER YIELDS AND / OR QUALITY IN EXPRESSION OF HETEROLOGICAL PROTEINS
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
WO2009002401A2 (en) 2007-06-21 2008-12-31 President And Fellows Of Harvard College Scaffolds for cell collection or elimination
JP2011506673A (en) 2007-12-14 2011-03-03 バイオティウム， インコーポレイテッド Fluorescent compound
GB0800938D0 (en) * 2008-01-18 2008-02-27 Ge Healthcare Uk Ltd Multiplex cell signalling assay
US9370558B2 (en) 2008-02-13 2016-06-21 President And Fellows Of Harvard College Controlled delivery of TLR agonists in structural polymeric devices
JP5690143B2 (en) 2008-02-13 2015-03-25 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Continuous cell programming device
EP3369827B1 (en) 2008-03-12 2020-12-23 The Rockefeller University Methods and compositions for translational profiling and molecular phenotyping
EP2947097A1 (en) 2008-04-07 2015-11-25 Ablynx N.V. Amino acid sequences directed against the Notch pathways and uses thereof
WO2009146456A1 (en) * 2008-05-30 2009-12-03 President And Fellows Of Harvard College Controlled release of growth factors and signaling molecules for promoting angiogenesis
US20100017232A1 (en) * 2008-07-18 2010-01-21 StevenDale Software, LLC Information Transmittal And Notification System
EP2318039B1 (en) * 2008-07-22 2015-04-08 Fibrostatin, Sociedad Limitada Goodpasture antigen binding protein and its detection
US9334281B2 (en) * 2008-09-08 2016-05-10 Enzo Life Sciences, Inc. Fluorochromes for organelle tracing and multi-color imaging
US9250249B2 (en) 2008-09-08 2016-02-02 Enzo Biochem, Inc. Autophagy and phospholipidosis pathway assays
CA2747644C (en) 2008-12-19 2023-01-24 Ablynx N.V. Method for generation of immunoglobulin sequences
WO2010115998A2 (en) 2009-04-10 2010-10-14 Ablynx Nv Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
US9297005B2 (en) 2009-04-13 2016-03-29 President And Fellows Of Harvard College Harnessing cell dynamics to engineer materials
CA2764398A1 (en) 2009-06-05 2010-12-09 Erik Depla Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
CA2768552A1 (en) 2009-07-31 2011-02-03 President And Fellows Of Harvard College Programming of cells for tolerogenic therapies
US8741591B2 (en) 2009-10-09 2014-06-03 The Research Foundation For The State University Of New York pH-insensitive glucose indicator protein
US8658434B2 (en) * 2009-10-28 2014-02-25 Biotium, Inc. Fluorescent pyrene compounds
WO2011064382A1 (en) 2009-11-30 2011-06-03 Ablynx N.V. Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
WO2011083140A1 (en) 2010-01-08 2011-07-14 Ablynx Nv Immunoglobulin single variable domain directed against human cxcr4
DE102010009445A1 (en) 2010-02-25 2011-08-25 Universitätsklinikum Jena, 07743 Expression vector comprising promoter, interfaces to insert use-specific gene sequence and genetic information expressing enzyme, useful to express peptide-inhibited small interfering RNA cleaving enzyme, preferably protease or peptidase
EP2542230A4 (en) 2010-03-05 2013-08-28 Harvard College Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1
WO2011163669A2 (en) 2010-06-25 2011-12-29 President And Fellows Of Harvard College Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones
AU2011272941B2 (en) 2010-06-30 2014-05-29 Compugen Ltd. C10RF32 for the treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disorders
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
CA2807942C (en) 2010-08-10 2021-07-27 Ecole Polytechnique Federale De Lausanne Erythrocyte-binding therapeutics
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
CN103221070B (en) 2010-08-30 2019-07-12 哈佛大学校长及研究员协会 Shear for stenotic lesion and thrombolytic therapy controls release
US8999335B2 (en) 2010-09-17 2015-04-07 Compugen Ltd. Compositions and methods for treatment of drug resistant multiple myeloma
CN107648668B (en) 2010-10-06 2021-06-18 哈佛学院董事会 Injectable pore-forming hydrogels for material-based cell therapy
US9603894B2 (en) 2010-11-08 2017-03-28 President And Fellows Of Harvard College Materials presenting notch signaling molecules to control cell behavior
MX2013009647A (en) 2011-02-21 2014-02-03 Fibrostatin S L Methods for treating and diagnosing disease.
WO2012148684A1 (en) 2011-04-27 2012-11-01 President And Fellows Of Harvard College Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
ES2685327T3 (en) 2011-04-28 2018-10-08 President And Fellows Of Harvard College Injectable preformed macroscopic three-dimensional frames for minimally invasive administration
CA2836791A1 (en) 2011-05-20 2012-11-29 Benjamin Wolozin Identification of compounds that disperse tdp-43 inclusions
WO2012167230A1 (en) 2011-06-03 2012-12-06 President And Fellows Of Harvard College In situ antigen-generating cancer vaccine
ES2610779T3 (en) 2011-08-23 2017-05-03 President And Fellows Of Harvard College Nanoparticles of peptides and uses thereof
GB201121565D0 (en) 2011-12-15 2012-01-25 Fundaci Privada Ct De Regulaci Gen Mica Crg Engineering fluorescent proteins for enhanced fret and uses thereof
GB201121570D0 (en) 2011-12-15 2012-01-25 Fundaci Privada Ct De Regulaci Gen Mica Crg Methods for producing engineered fluorescent proteins for enhanced fret, products and uses thereof
WO2013096851A1 (en) 2011-12-22 2013-06-27 President And Fellows Of Harvard College Compositions and methods for analyte detection
WO2013130808A1 (en) 2012-02-29 2013-09-06 D.E. Shaw Research, Llc Methods for screening voltage gated proteins
EP3662896B1 (en) 2012-04-16 2024-02-28 President and Fellows of Harvard College Mesoporous silica compositions for modulating immune responses
JP6388575B2 (en) 2012-06-06 2018-09-12 アメリカ合衆国 Kit for detecting and monitoring endocrine disrupting substances (EDC)
EP2866835A1 (en) 2012-07-02 2015-05-06 Fibrostatin, S.L. Gpbp-1 inhibition and its therapeutic use
US9682123B2 (en) 2013-12-20 2017-06-20 The Trustees Of Columbia University In The City Of New York Methods of treating metabolic disease
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
SG10202010936RA (en) 2014-02-21 2020-12-30 Ecole Polytecnique Fed De Lausanne Epfl Epfl Tto Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
CA2945945C (en) 2014-04-15 2023-10-03 The Regents Of The University Of California Bi-terminal pegylated integrin-binding peptides and methods of use thereof
JP7348708B2 (en) 2014-04-30 2023-09-21 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Combination vaccine device and method for killing cancer cells
NL2013661B1 (en) 2014-10-21 2016-10-05 Ablynx Nv KV1.3 Binding immunoglobulins.
WO2016007886A1 (en) 2014-07-11 2016-01-14 Northwestern University Yeast-based biosensor
WO2016090313A1 (en) 2014-12-05 2016-06-09 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use
WO2016090317A1 (en) 2014-12-05 2016-06-09 Aquinnah Pharmaceuticals, Inc. Sulfonamide derivatives, compositions and methods of use in the treatment of neurodegenerative diseases
US11786457B2 (en) 2015-01-30 2023-10-17 President And Fellows Of Harvard College Peritumoral and intratumoral materials for cancer therapy
EP3280464A4 (en) 2015-04-10 2018-09-26 President and Fellows of Harvard College Immune cell trapping devices and methods for making and using the same
US20180305451A1 (en) 2015-07-13 2018-10-25 Compugen Ltd. Hide1 compositions and methods
AU2016321298A1 (en) 2015-09-09 2018-03-29 The Trustees Of Columbia University In The City Of New York Reduction of ER-MAM localized APP-C99 and methods of treating Alzheimer's Disease
WO2017066705A1 (en) 2015-10-14 2017-04-20 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use against stress granules
WO2017064657A1 (en) 2015-10-16 2017-04-20 Invictus Oncology Pvt. Ltd. Fluorescent anticancer platinum drugs
CN115487351A (en) 2016-02-06 2022-12-20 哈佛学院校长同事会 Remodeling hematopoietic niches to reconstitute immunity
MA45738A (en) 2016-07-13 2019-05-22 Harvard College MIMETIC SCAFFOLDING OF ANTIGEN PRESENT CELLS AND METHODS FOR PREPARING AND USING THEM
US11840569B2 (en) 2016-11-16 2023-12-12 Ablynx N.V. T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta
WO2018232176A1 (en) 2017-06-16 2018-12-20 The University Of Chicago Compositions and methods for inducing immune tolerance
WO2019136421A1 (en) * 2018-01-08 2019-07-11 Lucidicor Inc. Fluorescent protein biosensor for detection of kinase activity
WO2019162521A1 (en) 2018-02-26 2019-08-29 Ablynx Nv Improved nucleotide sequences encoding peptide linkers
CN114258399A (en) 2019-08-27 2022-03-29 奥斯瓦道·克鲁兹基金会 Protein container, polynucleotide, vector, expression cassette, cell, method for producing container, method for identifying pathogen or diagnosing disease, use of container, and diagnostic kit
CN116075725A (en) 2020-04-17 2023-05-05 瑞泽恩制药公司 Assay for coronavirus neutralizing antibodies
CN113265428B (en) * 2021-06-11 2023-03-14 东北林业大学 Detection system for constructing copper change in living cells by utilizing metallothionein and application
WO2023006893A1 (en) 2021-07-30 2023-02-02 Confo Therapeutics N.V. Compounds for the treatment of pain, in particular neuropathic pain, and/or other diseases or disorders that are associated with at2r and/or at2r mediated signaling

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8607563A1 (en) * 1983-10-13 1986-06-01 Univ Georgia Res Found Bioluminescent immunoassays.
JPS6439990A (en) * 1987-08-05 1989-02-10 Chisso Corp Fused gene by bonding aequorin gene to functional gene
GB8916806D0 (en) * 1989-07-22 1989-09-06 Univ Wales Medicine Modified proteins
GB9310978D0 (en) * 1993-05-27 1993-07-14 Zeneca Ltd Compounds
US5491084A (en) * 1993-09-10 1996-02-13 The Trustees Of Columbia University In The City Of New York Uses of green-fluorescent protein
US6146826A (en) * 1993-09-10 2000-11-14 The Trustees Of Columbia University In The City Of New York Green fluorescent protein
WO1995021191A1 (en) * 1994-02-04 1995-08-10 William Ward Bioluminescent indicator based upon the expression of a gene for a modified green-fluorescent protein
US5795737A (en) * 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US5625048A (en) * 1994-11-10 1997-04-29 The Regents Of The University Of California Modified green fluorescent proteins
US5777079A (en) * 1994-11-10 1998-07-07 The Regents Of The University Of California Modified green fluorescent proteins
DE69618350T2 (en) * 1995-01-31 2002-09-19 Bioimage As Soeborg A METHOD FOR DETECTING BIOLOGICALLY ACTIVE SUBSTANCES
US5958713A (en) * 1995-01-31 1999-09-28 Novo Nordisk A/S Method of detecting biologically active substances by using green fluorescent protein
WO1996027027A1 (en) * 1995-03-02 1996-09-06 Rutgers The State University Of New Jersey Improved method for purifying green fluorescent protein
GB9504446D0 (en) * 1995-03-06 1995-04-26 Medical Res Council Improvements in or relating to gene expression
US5741657A (en) 1995-03-20 1998-04-21 The Regents Of The University Of California Fluorogenic substrates for β-lactamase and methods of use
US6342379B1 (en) 1995-06-07 2002-01-29 The Regents Of The University Of California Detection of transmembrane potentials by optical methods
DE69604298T2 (en) * 1995-09-22 2000-05-18 Bioimage A S Soeborg VARIANTS OF THE GREEN FLUORESCENCE PROTEIN, GFP
US5874304A (en) * 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
US6803188B1 (en) 1996-01-31 2004-10-12 The Regents Of The University Of California Tandem fluorescent protein constructs
US5804387A (en) * 1996-02-01 1998-09-08 The Board Of Trustees Of The Leland Stanford Junior University FACS-optimized mutants of the green fluorescent protein (GFP)
US6027881A (en) * 1996-05-08 2000-02-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence
US5912137A (en) 1996-07-16 1999-06-15 The Regents Of The University Of California Assays for protein kinases using fluorescent
US5925558A (en) 1996-07-16 1999-07-20 The Regents Of The University Of California Assays for protein kinases using fluorescent protein substrates
US6124128A (en) 1996-08-16 2000-09-26 The Regents Of The University Of California Long wavelength engineered fluorescent proteins
US6593135B2 (en) 1996-08-16 2003-07-15 The State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Long wavelength engineered fluorescent proteins
WO1998021355A1 (en) * 1996-11-15 1998-05-22 Life Technologies, Inc. Mutants of green fluorescent protein
CA2281648A1 (en) * 1997-02-13 1998-08-20 Memorial Sloan-Kettering Cancer Center Hybrid molecules for optically detecting changes in cellular microenvironments
US6197928B1 (en) 1997-03-14 2001-03-06 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
US5998204A (en) 1997-03-14 1999-12-07 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
US6046925A (en) 1997-04-14 2000-04-04 The Regents Of The University Of California Photochromic fluorescent proteins and optical memory storage devices based on fluorescent proteins
US6008378A (en) 1997-10-21 1999-12-28 The Regents Of The University Of California Synthetic molecules that specifically react with target sequences
US6140132A (en) 1998-06-09 2000-10-31 The Regents Of The University Of California Fluorescent protein sensors for measuring the pH of a biological sample
US6150176A (en) 1998-06-09 2000-11-21 The Regents Of The University Of California Fluorescent protein sensors for measuring the pH of a biological sample
US6469154B1 (en) 1999-05-21 2002-10-22 The Regents Of The University Of California Fluorescent protein indicators
US7060793B2 (en) 1999-05-21 2006-06-13 The Regents Of The University Of California Circularly permuted fluorescent protein indicators
US6778966B2 (en) 1999-11-29 2004-08-17 Syfx Segmented mapping converter system and method
US7015310B2 (en) 2001-03-12 2006-03-21 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Oxidation reduction sensitive green fluorescent protein variants

Also Published As

Publication number Publication date
EP0886644A4 (en) 2000-01-19
WO1998006737A1 (en) 1998-02-19
ES2231890T3 (en) 2005-05-16
DK0886644T3 (en) 2005-03-14
JP2001506842A (en) 2001-05-29
US20050079525A1 (en) 2005-04-14
EP1508574A3 (en) 2005-11-30
EP0886644B1 (en) 2004-10-20
CA2232242C (en) 2008-10-21
AU4327797A (en) 1998-03-06
US6780975B2 (en) 2004-08-24
US6124128A (en) 2000-09-26
DE69731285D1 (en) 2004-11-25
ATE280178T1 (en) 2004-11-15
US6077707A (en) 2000-06-20
US20030036178A1 (en) 2003-02-20
US7560287B2 (en) 2009-07-14
US6054321A (en) 2000-04-25
EP0886644A1 (en) 1998-12-30
DE69731285T2 (en) 2006-03-09
EP1508574A2 (en) 2005-02-23
US6403374B1 (en) 2002-06-11
JP4232992B2 (en) 2009-03-04
AU727088B2 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
CA2232242A1 (en) Long wavelength engineered fluorescent proteins
CA2258502A1 (en) Modified factor viii
WO1997007198A3 (en) Dna sequences and secreted proteins encoded thereby
AU8400398A (en) Nucleic acid encoding a novel chemotherapy-induced protein, and methods of use
AU8264898A (en) Human jagged polypeptide, encoding nucleic acids and methods of use
WO2000006738A3 (en) NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE)
AU5264498A (en) Genes encoding telomerase proteins
AU6667998A (en) Nucleic acids encoding caspase-8h and caspase-8i
WO2001090147A3 (en) Long wavelength engineered fluorescent proteins
AU2001238212A1 (en) Modified fluorescent proteins
ZA9710163B (en) Novel carboxylesterase nucleic acid molecules, proteins and uses thereof.
AU1952497A (en) Novel antibody-cytokine fusion protein, and methods of making and using the same
AU3670395A (en) Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
AU1981295A (en) Novel protein-kinase, nucleic acid sequences encoding the same and methods related thereto
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
AU1440695A (en) P53-based polypeptide fragments, nucleic acid molecules encoding same, and uses thereof
CA2199403A1 (en) Novel PKA-Binding Proteins and Uses Thereof
AU5253898A (en) Recombinant by55 and nucleic acids encoding same
WO1998024896A3 (en) Muteins of obese protein
AU5137698A (en) Novel dna, novel protein, and novel antibody
AU3955099A (en) Novel gene and protein encoded thereby
AU1525499A (en) Ikap proteins, nucleic acids and methods
AU4219397A (en) Novel protein, its production and use
AU1574699A (en) Nucleic acids encoding (hev) structural proteins, (hev) structural proteins encoded thereby and uses thereof
AU1693995A (en) Phosphacan, nucleic acids encoding thereof and antibodies thereto

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170815